Gossamer Bio Inc.
Organization details
- Legal name
- Gossamer Bio Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- GOSS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001728117
- EIN
- 47-5461709
Board of directors
-
Faheem Hasnain · Director · President & CEOSince 2023
-
Gregory Austin Ciongoli · DirectorSince 2026
-
John D. Quisel · DirectorSince 2023
- Since 2023
-
Renee D. Gala · DirectorSince 2023
-
Russell J. Cox · DirectorSince 2023
-
Sandra Milligan · DirectorSince 2023
-
Skye Drynan · DirectorSince 2024
-
Steven D. Nathan · DirectorSince 2024
-
Thomas O. Daniel · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
74.8%
-
77.6%
Board connections
7 of this board's directors also sit on 14 other boards. 14 are in the same sector.
-
Spyre Therapeutics Inc. Same sectorvia Russell J. Cox and Sandra Milligan
-
Aspen Neuroscience Inc. Same sectorvia Faheem Hasnain
-
Atara Biotherapeutics Inc. Same sectorvia Gregory Austin Ciongoli
-
Beam Therapeutics Inc. Same sectorvia Kristina Burow
-
Boundless Bio Inc. Same sectorvia Kristina Burow
-
DexCom Inc. Same sectorvia Renee D. Gala
-
Disc Medicine Inc. Same sectorvia John D. Quisel
-
Jazz Pharmaceuticals plc Same sectorvia Renee D. Gala
-
Kardigan Inc. Same sectorvia Kristina Burow
-
Kura Oncology Inc. Same sectorvia Faheem Hasnain
-
Neumora Therapeutics Inc. Same sectorvia Kristina Burow
-
REGENXBIO Inc. Same sectorvia Gregory Austin Ciongoli
-
Scholar Rock Holding Corporation Same sectorvia Kristina Burow
-
Zymeworks Inc. Same sectorvia Gregory Austin Ciongoli
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Faheem Hasnain Director, Officer (President & CEO) | Grant or award | +280,000 | — | — |
| Jan 2, 2026 | Bryan Giraudo Officer (COO/CFO) | Grant or award | +115,750 | — | — |
| Jan 2, 2026 | Smith Robert Paul JR Officer (Chief Commercial Officer) | Grant or award | +93,750 | — | — |
| Jan 2, 2026 | Aranda Richard Officer (Chief Medical Officer) | Grant or award | +93,750 | — | — |
| Jan 2, 2026 | Peterson Caryn Officer (EVP, Regulatory Affairs) | Grant or award | +84,500 | — | — |
| Jan 2, 2026 | Waage Christian Officer (EVP, Tech Ops and Admin) | Grant or award | +84,500 | — | — |
| Oct 1, 2025 | Smith Robert Paul JR Officer (Chief Commercial Officer) | Grant or award | +162,500 | — | — |
| Oct 1, 2025 | Waage Christian Officer (EVP, Tech Ops and Admin) | Grant or award | +125,000 | — | — |
| Oct 1, 2025 | Bryan Giraudo Officer (COO/CFO) | Grant or award | +181,250 | — | — |
| Oct 1, 2025 | Aranda Richard Officer (Chief Medical Officer) | Grant or award | +162,500 | — | — |
| Oct 1, 2025 | Faheem Hasnain Director, Officer (President & CEO) | Grant or award | +437,500 | — | — |
| Oct 1, 2025 | Peterson Caryn Officer (EVP, Regulatory Affairs) | Grant or award | +125,000 | — | — |
| Aug 19, 2025 | Sandra Milligan Director | Open-market purchase | +26,050 | $1.92 | $50,016 |
| Jun 24, 2024 | Aranda Richard Officer (Chief Medical Officer) | Open-market sale | −1,908 | $0.66 | $1,259 |
| Jun 21, 2024 | Faheem Hasnain Director, Officer (President & CEO) | Open-market purchase | +372,000 | $0.67 | $249,240 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Gossamer Bio Inc.
Who is the CEO of Gossamer Bio Inc.?
Faheem Hasnain is Gossamer Bio Inc.'s President & CEO.
How many directors are on Gossamer Bio Inc.'s board?
Gossamer Bio Inc.'s board has 10 directors: Faheem Hasnain, Gregory Austin Ciongoli, John D. Quisel, Kristina Burow, Renee D. Gala, Russell J. Cox, Sandra Milligan, Skye Drynan, Steven D. Nathan and Thomas O. Daniel.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="gossamer-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.